Vertex to End Sales of Hepatitis C Drug Telaprevir (Incivek)Vertex to End Sales of Hepatitis C Drug Telaprevir (Incivek)

Vertex Pharmaceuticals Inc is stopping U.S. sales and distribution of its hepatitis C drug telaprevir (Incivek), whose use has been largely supplanted by new-comer sofosbuvir (Sovaldi) from Gilead Sciences. Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Infectious Diseases News Source Type: news